Xcout Intel
MDI Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to MDI Therapeutics, Inc. among biotechnology companies — ranked by similarity to what MDI Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see MDI Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About MDI Therapeutics, Inc.
MDI Therapeutics, Inc. is a pharmaceutical company headquartered in Novi, Michigan. The company specializes in researching and developing novel therapeutics for the treatment of fibrosis and related fibrotic diseases.
MDI Therapeutics, Inc. at a glance
MDI Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $3.2M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round raised $1.7M in February 2022. Xcout tracks 7 named people at MDI Therapeutics, Inc., including Gillian Dines (CEO).
MDI Therapeutics, Inc. leadership
- Gillian DinesCEO
- Mark WeinbergChief Medical Officer
- Daniel A LawrenceFounder/Chairman, Clinical & Scientific Advisory Board
- Grazia PiizziDr. Grazia Piizzi, PhD
- Laurie McFetridgeLaurie McFetridge
- Stephen BenoitStephen Benoit
1 more named person on record for MDI Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
MDI Therapeutics, Inc. funding rounds
At least $3.2M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.7M | — | |
| SEC Form D filing | $1.6M | — | |
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 MDI Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to MDI Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Mediar Therapeutics is a clinical-stage biotechnology company that develops novel antibody therapies to halt and reverse fibrotic diseases. The company focuses on deactivating myofibroblasts to treat conditions such as idiopathic pulmonary fibrosis (IPF), systemic sclerosis (SSc), and kidney fibrosis.
Similar biotechnology company
Endeavor BioMedicines, Inc. is a San Diego-based biotechnology company focused on developing novel treatments for conditions such as fibrosis.
Similar biotechnology company
FibroGenesis is a U.S. biotechnology company focused on developing therapies for fibrosis and related fibrotic diseases. Its work is intended to serve patients with serious disorders in which excessive scar-tissue formation damages organs or tissues.
Similar biotechnology company
Certa Therapeutics is a private biotechnology company headquartered in Melbourne, Australia, focused on developing innovative precision therapies for the treatment of fibrotic diseases.
Similar biotechnology company
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company located in Mission Viejo, California, focused on developing a platform of compounds for biodefense and fibrosis applications.
Similar biotechnology company
4F Biotech is a biotechnology firm focused on developing innovative therapeutic approaches, screening platforms, and diagnostic tools to combat fibrosis and inflammatory processes.
Similar biotechnology company
NanoBio Corp. is a biopharmaceutical company based in Ann Arbor, Michigan, focused on developing dermatological products and anti-infective treatments.
Similar biotechnology company
ONL Therapeutics, Inc. is a clinical-stage biopharmaceutical company located in Michigan, United States, focused on the development of novel therapies for retinal diseases.
Similar biotechnology company
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Grand Rapids, Michigan, focused on developing innovative therapies for metabolic and liver diseases.
Biotech
Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials for several other conditions, including dermatomyositis and interstitial lung disease linked to systemic sclerosis, pneumoconiosis, and diabetic kidney disease. The company's pipeline further includes F351 (Hydronidone), a compound structurally related to ETUARY. F351 is currently in Phase 3 studies for chronic hepatitis B-induced liver fibrosis and is in Phase 1 trials for liver fibrosis associated with nonalcoholic associated steatohepatitis (NASH). Other programs in development feature F573, which is progressing through Phase 2 studies for acute and acute-on-chronic liver failure. Additionally, two early-stage candidates, F528 and F230, are in preclinical development, focusing on chronic obstructive pulmonary disease (COPD) and pulmonary arterial hypertension (PAH), respectively. Established in 2002, Gyre Therapeutics, Inc. is based in San Diego, California, and operates as a subsidiary of GNI USA, Inc.
Similar biotechnology company
Liminal BioSciences is a biopharmaceutical company headquartered in Laval, Quebec, Canada, focused on developing innovative small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases.
Similar biotechnology company
AllRock Bio is a clinical-stage biotechnology company headquartered in Natick, Massachusetts, dedicated to developing transformative therapies for cardiopulmonary and fibrotic conditions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of MDI Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for MDI Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →